Showing results (211-220 of 319) with videos related to
Sort By:
Pageof 32
JCO Oncology Practice|February 3, 2021
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial ImplementationCathy Eng, Emerson Y Chen, Jane Rogers, et al.Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.The Lancet. Oncology|April 21, 2019
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trialCathy Eng, Tae Won Kim, Johanna Bendell, et al.Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.Journal of the American College of Surgeons|January 16, 2017
Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single InstitutionEugene A Woltering, Brianne A Voros, David T Beyer, et al.International Journal of Cancer|February 19, 2016
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapyCathy Eng, Alberto Bessudo, Lowell L Hart, et al.International Journal of Clinical Oncology|September 1, 2025
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in JapanDaisuke Kotani, Takayuki Yoshino, Toshiki Masuishi, et al.Oncotarget|November 7, 2014
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canalCathy Eng, George J Chang, Y Nancy You, et al.JAMA Network Open|May 24, 2022
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic ReviewChan Shen, Daniel Tannenbaum, Robert Horn, et al.American Journal of Clinical Oncology|March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation TherapyIn J Park, Y Nancy You, John M Skibber, et al.Pageof 32